Literature DB >> 21645850

The deletion of exon 3 in the cardiac ryanodine receptor is rescued by β strand switching.

Paolo A Lobo1, Lynn Kimlicka, Ching-Chieh Tung, Filip Van Petegem.   

Abstract

Mutations in the cardiac Ryanodine Receptor (RYR2) are linked to triggered arrhythmias. Removal of exon 3 results in a severe form of catecholaminergic polymorphic ventricular tachycardia (CPVT). This exon encodes secondary structure elements that are crucial for folding of the N-terminal domain (NTD), raising the question of why the deletion is neither lethal nor confers a loss of function. We determined the 2.3 Å crystal structure of the NTD lacking exon 3. The removal causes a structural rescue whereby a flexible loop inserts itself into the β trefoil domain and increases thermal stability. The exon 3 deletion is not tolerated in the corresponding RYR1 domain. The rescue shows a novel mechanism by which RYR2 channels can adjust their Ca²⁺ release properties through altering the structure of the NTD. Despite the rescue, the deletion affects interfaces with other RYR2 domains. We propose that relative movement of the NTD is allosterically coupled to the pore region.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645850     DOI: 10.1016/j.str.2011.03.016

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  25 in total

Review 1.  A network-oriented perspective on cardiac calcium signaling.

Authors:  Christopher H George; Dimitris Parthimos; Nicole C Silvester
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249

Review 2.  Ryanodine receptors: structure and function.

Authors:  Filip Van Petegem
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

3.  Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.

Authors:  Yijun Tang; Xixi Tian; Ruiwu Wang; Michael Fill; S R Wayne Chen
Journal:  Circ Res       Date:  2012-02-28       Impact factor: 17.367

4.  Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination.

Authors:  Yingjie Liu; Bo Sun; Zhichao Xiao; Ruiwu Wang; Wenting Guo; Joe Z Zhang; Tao Mi; Yundi Wang; Peter P Jones; Filip Van Petegem; S R Wayne Chen
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

Review 5.  Calcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patients.

Authors:  Xiao-Hua Zhang; Martin Morad
Journal:  Cell Calcium       Date:  2015-12-15       Impact factor: 6.817

6.  The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating.

Authors:  Bo Sun; Wenting Guo; Xixi Tian; Jinjing Yao; Lin Zhang; Ruiwu Wang; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-27       Impact factor: 5.157

7.  Crystallographic insights into sodium-channel modulation by the β4 subunit.

Authors:  John Gilchrist; Samir Das; Filip Van Petegem; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Modeling a ryanodine receptor N-terminal domain connecting the central vestibule and the corner clamp region.

Authors:  Li Zhu; Xiaowei Zhong; S R Wayne Chen; Nilesh Banavali; Zheng Liu
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

9.  Identification of Avian Corticosteroid-binding Globulin (SerpinA6) Reveals the Molecular Basis of Evolutionary Adaptations in SerpinA6 Structure and Function as a Steroid-binding Protein.

Authors:  Ganna Vashchenko; Samir Das; Kyung-Mee Moon; Jason C Rogalski; Matthew D Taves; Kiran K Soma; Filip Van Petegem; Leonard J Foster; Geoffrey L Hammond
Journal:  J Biol Chem       Date:  2016-03-29       Impact factor: 5.157

10.  Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.

Authors:  R P Pölönen; H Swan; K Aalto-Setälä
Journal:  Mol Biol Rep       Date:  2019-11-30       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.